tanshinone ii a has been researched along with thiolactomycin in 1 studies
| Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (thiolactomycin) | Trials (thiolactomycin) | Recent Studies (post-2010) (thiolactomycin) |
|---|---|---|---|---|---|
| 61 | 0 | 41 | 99 | 0 | 19 |
| Protein | Taxonomy | tanshinone ii a (IC50) | thiolactomycin (IC50) |
|---|---|---|---|
| DNA-(apurinic or apyrimidinic site) endonuclease | Homo sapiens (human) | 1 | |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Mycobacterium tuberculosis H37Rv | 4 | |
| 3-oxoacyl-[acyl-carrier-protein] synthase 2 | Mycobacterium tuberculosis H37Rv | 6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laev, SS; Lavrik, OI; Salakhutdinov, NF | 1 |
1 review(s) available for tanshinone ii a and thiolactomycin
| Article | Year |
|---|---|
Inhibitors of nuclease and redox activity of apurinic/apyrimidinic endonuclease 1/redox effector factor 1 (APE1/Ref-1).
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA Repair; DNA-(Apurinic or Apyrimidinic Site) Lyase; Enzyme Inhibitors; Humans; Neoplasms; Oxidation-Reduction | 2017 |